METHODS AND COMPOSITIONS FOR TARGETING UNDERGLYCOSYLATED PROTEINS ACROSS THE BLOOD BRAIN BARRIER

Details for Australian Patent Application No. 2002362930 (hide)

Owner SYMBIONTICS INC.

Inventors LEBOWITZ, Jonathan, H.; SLY, Wilian, S.

Pub. Number AU-A-2002362930

PCT Number PCT/US02/32968

PCT Pub. Number WO2003/032727

Priority 60/329,650 16.10.01 US; 10/136,841 30.04.02 US; 10/136,639 30.04.02 US; 60/384,452 29.05.02 US; 60/386,019 05.06.02 US; 60/408,816 06.09.02 US

Filing date 16 October 2002

Wipo publication date 28 April 2003

International Classifications

A01N 037/18 Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

C12N 015/74 Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C07K 001/00 General processes for the preparation of peptides

C07K 014/00 Peptides having more than 20 amino acids

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 017/00 Carrier-bound or immobilised peptides

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 038/00 Medicinal preparations containing peptides

C12P 021/06 Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 005/02 Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

Event Publications

22 May 2003 Complete Application Filed

  Priority application(s): 60/329,650 16.10.01 US; 10/136,841 30.04.02 US; 10/136,639 30.04.02 US; 60/384,452 29.05.02 US; 60/386,019 05.06.02 US; 60/408,816 06.09.02 US

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002362930

5 August 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Apr 2004

9 December 2004 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor from Sly, Wilian S to Sly, William S. 2003

27 January 2005 Assignment before Grant

  Symbiontics, Inc. The application has been assigned to ZyStor Therapeutics, Inc.

13 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002362931-APPARATUS FOR INJECTION MOLDING MULTILAYERED ARTICLES

2002362929-Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts